To verify the protein array results, we performed Western blots and confirmed CUDC-101 treatment reduced the level of survivin, XIAP, and β-catenin, which are upregulated in ATC and contribute to the highly aggressive behavior of this tumor (Figure 5D) [19, 26, 27]. The gene discussed is XIAP; the disease is neoplasm.